Clinical Trial

Precision Medicine Trial Based on Molecular Matching Therapy for Patients With Standard Treatment Exhaustion

Name: Precision Medicine Trial Based on Molecular Matching Therapy for Patients With Standard Treatment Exhaustion — clinical trial record (NCT06739395)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

The main purpose of this study is to explore the feasibility of selecting treatment plans based on genomic variations guided by MTB in patients with advanced refractory solid tumors.

Trial Details

NCT Number	NCT06739395
Lead Sponsor	Tianjin Medical University Second Hospital
Conditions	Solid Tumor, Precision Medicine
Enrollment	300 participants
Start Date	2024-11-01
Primary Completion	2026-12-31 (estimated)
Study Completion	2027-05-01 (estimated)
Updated on ClinicalTrials.gov	2024-12-18